These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Effect of length of treatment with Bayer 2502 on isolation of Trypanosoma cruzi and resistance to challenge in the mouse. Morrow DT; Wescott RB; Davis WC Am J Trop Med Hyg; 1977 May; 26(3):382-6. PubMed ID: 405877 [TBL] [Abstract][Full Text] [Related]
7. Molecular and biological characterization of a highly pathogenic Trypanosoma cruzi strain isolated from a patient with congenital infection. Gulin JEN; Bisio M; Rocco DM; Altcheh J; Solana ME; García-Bournissen F Exp Parasitol; 2018 Mar; 186():50-58. PubMed ID: 29448038 [TBL] [Abstract][Full Text] [Related]
8. Effects of juvenile hormone analogues (JHA) on the development of Trypanosoma cruzi. Fichera L; Esteva M; Wimmer Z; Rodriguez JB; Gros EG Z Naturforsch C J Biosci; 1995; 50(7-8):578-80. PubMed ID: 7546047 [TBL] [Abstract][Full Text] [Related]
9. 5-Nitro-2-furyl derivative actives against Trypanosoma cruzi: preliminary in vivo studies. Cabrera E; Murguiondo MG; Arias MG; Arredondo C; Pintos C; Aguirre G; Fernández M; Basmadjián Y; Rosa R; Pacheco JP; Raymondo S; Di Maio R; González M; Cerecetto H Eur J Med Chem; 2009 Oct; 44(10):3909-14. PubMed ID: 19446929 [TBL] [Abstract][Full Text] [Related]
10. Design, structure-activity relationship and in vivo efficacy of piperazine analogues of fenarimol as inhibitors of Trypanosoma cruzi. Keenan M; Alexander PW; Diao H; Best WM; Khong A; Kerfoot M; Thompson RC; White KL; Shackleford DM; Ryan E; Gregg AD; Charman SA; von Geldern TW; Scandale I; Chatelain E Bioorg Med Chem; 2013 Apr; 21(7):1756-63. PubMed ID: 23462713 [TBL] [Abstract][Full Text] [Related]
11. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi. de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078 [TBL] [Abstract][Full Text] [Related]
13. Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease. Filardi LS; Brener Z Trans R Soc Trop Med Hyg; 1987; 81(5):755-9. PubMed ID: 3130683 [TBL] [Abstract][Full Text] [Related]
14. [Nifurtimox, a bright future for treatment of Chagas disease]. Wolf A; Boulliat C; Coillot C; Rouault M; Gaillard K; Beranger C; Oliver M Med Trop (Mars); 2011 Apr; 71(2):131-3. PubMed ID: 21695868 [TBL] [Abstract][Full Text] [Related]
15. In search of anti-Trypanosoma cruzi drugs: new leads from a mouse model. Kinnamon KE; Steck EA; Hanson WL; Chapman WL J Med Chem; 1977 Jun; 20(6):741-4. PubMed ID: 69024 [TBL] [Abstract][Full Text] [Related]
16. Enantiomers of nifurtimox do not exhibit stereoselective anti-Trypanosoma cruzi activity, toxicity, or pharmacokinetic properties. Moraes CB; White KL; Braillard S; Perez C; Goo J; Gaspar L; Shackleford DM; Cordeiro-da-Silva A; Thompson RC; Freitas-Junior L; Charman SA; Chatelain E Antimicrob Agents Chemother; 2015; 59(6):3645-7. PubMed ID: 25845874 [TBL] [Abstract][Full Text] [Related]
17. Trypanothione Reductase: A Target for the Development of Anti- Trypanosoma cruzi Drugs. Vázquez K; Paulino M; Salas CO; Zarate-Ramos JJ; Vera B; Rivera G Mini Rev Med Chem; 2017; 17(11):939-946. PubMed ID: 28302040 [TBL] [Abstract][Full Text] [Related]
18. Limitations of currently available Chagas disease chemotherapy. Murcia L; Carrilero B; Segovia M Rev Esp Quimioter; 2012 Mar; 25(1):1-3. PubMed ID: 22488534 [No Abstract] [Full Text] [Related]
19. Trypanosoma cruzi: chemotherapeutic effects of clomipramine in mice infected with an isolate obtained from an endemic area. Rivarola HW; Bustamante JM; Lo Presti S; Fernández AR; Enders JE; Gea S; Fretes R; Paglini-Oliva P Exp Parasitol; 2005 Oct; 111(2):80-6. PubMed ID: 16085036 [TBL] [Abstract][Full Text] [Related]
20. An update on benznidazole for the treatment of patients with Chagas disease. Thakare R; Dasgupta A; Chopra S Drugs Today (Barc); 2018 Jan; 54(1):15-23. PubMed ID: 29569658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]